Global Needle Free Injection System Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2024

Published - Apr 2019 | Category - Pharma & Healthcare | No. of Pages - 145 | Published By - EMR

Global needle free injection system market is expected to grow significantly from USD 2,267 million in 2017 to USD 5,785 million in 2024, at an exponential CAGR of 14.8% from 2018 to 2024.

The growth in the market is attributed to the increasing demand for self-injection devices. Moreover, increasing prevalence of chronic diseases and high incidences of needle stick injuries is also expected to fuel the market growth during the forecast period. Additionally, emerging applications of needle free injection system in biosimilar, vaccination, and local anesthetics are projected to propel the market growth during 2018-2024.

The needle-free injection system is a new approach to introduce various type of medicine into patient’s blood circulation. This technology has emerged as a safer, less painful and cost-effective alternative. The needle-free injection system delivers the drug through the skin using forces such as Lorentz, shock waves, pressure by gas, and electrophoresis. Moreover, strong demand for needle-free injection system is due to its emerging applications in biosimilar, vaccination, and local anesthetics. Furthermore, technological advancements in the needle-free injection system owing to increasing research and development activities are further expected to fuel the demand during the forecast period.

Global Needle Free Injection System Market Major Key Companies

Antares Pharma, Inc.
European Pharma Group
Crossject needle-free injection systems
Enable Injections
3M Company
Penjet Corporation
Zogenix, Inc.
B. Braun Melsungen AG


Quick Buy

Latest Publications